Searched for
BIO EQUIVALENCE
Taylor Swift becomes youngest woman in Songwriters Hall of FameTaylor Swift on Thursday became the youngest woman ever inducted into the prestigious Songwriters Hall of Fame, another milestone in the 36...- Over 100-year-old cooperative society transforming lives of farmers in PunjabA century-old cooperative in Punjab's Hoshiarpur district is empowering farmers with loans, equipment rentals, and ultra-low-cost biogas. T...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Deeptech bets heat up; Paytm, PB Fintech, Meesho earningsHappy Thursday! VCs are doubling down on India’s deeptech, with early-stage bets leading the charge. This and more in today’s ETtech Mornin...
- Govt overhauls six-decade-old sugarcane law; seeks comments on draft by May 20The Centre is proposing a new Sugarcane (Control) Order 2026, replacing the 1966 version to integrate ethanol production, digital complianc...
- ET MSME Awards 2025: India's pharma MSMEs face existential choiceNew bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...
- One AstraZeneca Covid vaccine dose gives 80% lower death risk: English dataThe study looked at new symptomatic cases of COVID-19 between December and April and people who died within 28 days of their positive test ...
- Transforming methane gas to meat equivalent. String Bio is making it possibleYour source of protein in the future may not be from the meat you eat, but from one of the most potent greenhouse gases. With five patents ...
- Granules India gets USFDA nod for allergy treatment drugGranules India said it has received approval for Fexofenadine Hydrochloride tablets. The approved product is bio-equivalent to the referenc...
- Sun Pharma shuts two clinical pharmacology units in VadodaraAs per industry sources, the move would impact around 80 staffers at the two locations.
- Aurobindo Pharma gets US Food and Drug Administration nod for two drugsThe drug is bio-equivalent and therapeutically equivalent to the reference listed product Pepcid AC Tablets -- 10 mg and 20 mg of McNeil Co...
- Mahindra inaugurates bio-CNG plant at Mahindra World CitySpread over 1,000 square metres, the facility will convert eight tonnes of food and kitchen waste generated daily at Mahindra World City.
- Germany suspends marketing of 54 drugs tested by GVK BiosciencesGermany's drug regulator has suspended the marketing of 54 medicines clinically tested by India's GVK Biosciences in compliance.
- Lupin submits fresh studies for two products suspended by EMALupin said that company has successfully conducted the new bio equivalence (BE) studies for the said products and submitted the report to E...
- European Union health regulators suspect manipulation by GVK BioRegulators in many European countries including Germany are reportedly evaluating whether to suspend the use of over 100 medicines.
- Dr Reddy's launches Amoxicillin tablets, capsules in US marketDr Reddy's today announced the launch of antibiotic Amoxicillin tablets, capsules and oral suspension.
- Health ministry suspends AP clinical research firm nod for clinical studyThe country’s drug regulator has suspended clinical research firm Axis Clinicals' permission to conduct all bio-availability and bio-equiva...
- Manipal AcuNova acquires German firm EcronClinical research firm Manipal AcuNova Ltd on Monday announced it has completed the acquisition of ECRON GmbH, Europe.
- Sun Pharm gets USFDA nod for generic Sinemet CRSun Pharmaceutical today said it has received US Food and Drug Administration's (USFDA) approval for its abbreviated new drug application (...
- Pharma cos eyeing US generic drugs spaceAt a time when the US generic drugs market is reeling under price competition, a recent move by the US government to accelerate approvals o...
Load More
